We’ve recently updated our valuation analysis.

MatsukiyoCocokara Valuation

Is 3088 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3088?

Other financial metrics that can be useful for relative valuation.

3088 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.8x
Enterprise Value/EBITDA10x
PEG Ratio3.1x

Price to Earnings Ratio vs Peers

How does 3088's PE Ratio compare to its peers?

The above table shows the PE ratio for 3088 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average22.2x
3141 Welcia Holdings
23.7x6.5%JP¥664.5b
3349 COSMOS Pharmaceutical
25.2x6.8%JP¥589.6b
3391 Tsuruha Holdings
21.8x3.5%JP¥466.4b
9989 SundrugLtd
18.2x5.1%JP¥439.6b
3088 MatsukiyoCocokara
19x6.1%JP¥811.0b

Price-To-Earnings vs Peers: 3088 is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (22.2x).


Price to Earnings Ratio vs Industry

How does 3088's PE Ratio compare vs other companies in the JP Consumer Retailing Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a6.8%
n/an/an/a

Price-To-Earnings vs Industry: 3088 is expensive based on its Price-To-Earnings Ratio (19x) compared to the JP Consumer Retailing industry average (13.4x)


Price to Earnings Ratio vs Fair Ratio

What is 3088's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3088 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19x
Fair PE Ratio21.3x

Price-To-Earnings vs Fair Ratio: 3088 is good value based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (21.3x).


Share Price vs Fair Value

What is the Fair Price of 3088 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3088 (¥5770) is trading below our estimate of fair value (¥8602.21)

Significantly Below Fair Value: 3088 is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3088 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥5,770.00
JP¥6,436.36
+11.5%
10.1%JP¥8,000.00JP¥5,100.00n/a11
Nov ’23JP¥5,430.00
JP¥6,245.45
+15.0%
7.3%JP¥7,000.00JP¥5,100.00n/a11
Oct ’23JP¥6,230.00
JP¥6,109.09
-1.9%
9.1%JP¥7,000.00JP¥5,100.00n/a11
Sep ’23JP¥5,580.00
JP¥6,027.27
+8.0%
9.8%JP¥7,000.00JP¥5,100.00n/a11
Aug ’23JP¥5,100.00
JP¥5,959.09
+16.8%
9.6%JP¥7,000.00JP¥5,100.00n/a11
Jul ’23JP¥5,460.00
JP¥5,886.36
+7.8%
11.5%JP¥7,000.00JP¥4,600.00n/a11
Jun ’23JP¥5,110.00
JP¥5,479.17
+7.2%
12.4%JP¥7,000.00JP¥4,400.00n/a12
May ’23JP¥4,305.00
JP¥5,375.00
+24.9%
14.3%JP¥7,300.00JP¥4,400.00n/a12
Apr ’23JP¥4,320.00
JP¥5,408.33
+25.2%
13.6%JP¥7,300.00JP¥4,600.00n/a12
Mar ’23JP¥4,355.00
JP¥5,666.67
+30.1%
13.9%JP¥7,300.00JP¥4,600.00n/a12
Feb ’23JP¥3,930.00
JP¥5,925.00
+50.8%
10.9%JP¥7,300.00JP¥5,200.00n/a12
Jan ’23JP¥4,260.00
JP¥5,983.33
+40.5%
10.3%JP¥7,300.00JP¥5,200.00n/a12
Dec ’22JP¥4,325.00
JP¥6,036.36
+39.6%
10.3%JP¥7,300.00JP¥5,200.00n/a11
Nov ’22JP¥5,210.00
JP¥5,840.00
+12.1%
10.1%JP¥7,300.00JP¥5,200.00JP¥5,430.0010
Oct ’22JP¥4,950.00
JP¥5,840.00
+18.0%
10.1%JP¥7,300.00JP¥5,200.00JP¥6,230.0010
Sep ’22JP¥5,040.00
JP¥5,800.00
+15.1%
9.8%JP¥7,300.00JP¥5,200.00JP¥5,580.0011
Aug ’22JP¥4,850.00
JP¥5,477.78
+12.9%
8.0%JP¥6,100.00JP¥4,800.00JP¥5,100.009
Jul ’22JP¥5,000.00
JP¥5,466.67
+9.3%
8.1%JP¥6,100.00JP¥4,800.00JP¥5,460.009
Jun ’22JP¥4,730.00
JP¥5,466.67
+15.6%
8.1%JP¥6,100.00JP¥4,800.00JP¥5,110.009
May ’22JP¥4,385.00
JP¥5,566.67
+26.9%
7.7%JP¥6,100.00JP¥4,800.00JP¥4,305.009
Apr ’22JP¥4,865.00
JP¥5,466.67
+12.4%
10.4%JP¥6,100.00JP¥4,500.00JP¥4,320.009
Mar ’22JP¥4,770.00
JP¥5,350.00
+12.2%
10.1%JP¥6,100.00JP¥4,500.00JP¥4,355.008
Feb ’22JP¥4,165.00
JP¥5,211.11
+25.1%
9.3%JP¥6,000.00JP¥4,500.00JP¥3,930.009
Jan ’22JP¥4,400.00
JP¥5,088.89
+15.7%
11.4%JP¥6,000.00JP¥4,200.00JP¥4,260.009
Dec ’21JP¥4,885.00
JP¥5,040.00
+3.2%
11.3%JP¥6,000.00JP¥4,200.00JP¥4,325.0010
Nov ’21JP¥3,855.00
JP¥4,545.00
+17.9%
8.8%JP¥5,500.00JP¥4,000.00JP¥5,210.0010

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies